Practice-Changing Oncology

From Global Evidence to African Impact

The most important practice-changing studies of 2026 and what they mean for patients in Africa.

Date

Jun 24, 2026

Time

12PM CT · 6PM Tunisia

Format

Zoom · 60 min · Q&A

ABOUT THIS SESSION

Global evidence, African implementation.

Each month, the African Healthcare Association brings together leading clinicians, researchers, and global health partners to share the evidence and innovations shaping patient care across the continent. The June 2026 session zeroes in on the practice-changing oncology studies of the year, with a deliberate focus on how these advances can be translated into real-world impact for African patients.

Featuring Dr. Nesrine Mejri, a leading medical oncologist from Tunisia and principal investigator on multiple international phase III trials, alongside Dr. Ray Mankoski, a strategic healthcare leader with more than 15 years of global biopharma experience, this conversation moves beyond headlines to examine feasibility, timing, and the conditions African health systems need to adopt new standards of care.

Clinicians, researchers, public health professionals, and health system leaders are invited to join the discussion, ask questions, and take away actionable insights they can apply to their work.

FEATURED SPEAKERS

A multidisciplinary lineup.

Pairing African clinical leadership with global biopharma strategy.

Medical Oncology · Tunis, Tunisia

Dr. Nesrine Mejri, MD

Head of Department, Associate Professor of Medical Oncology, Faculty of Medicine of Tunis, University of Tunis El Manar

Associate Professor of Medical Oncology at the University of Tunis El Manar and Head of Medical Oncology at Abderrahmen Mami Hospital since 2025. Her expertise spans thoracic oncology, breast cancer, and multidisciplinary care. She has led several international phase III trials including INAVO122 and BENITO, and national studies such as LUNG-TUN. With over 50 peer-reviewed publications, 580+ citations, and an H-index of 13, she has contributed to national breast cancer guidelines and delivered over 150 conference presentations. Fluent in Arabic, French, and English.

Strategic Healthcare Leader · Nemetz Consulting

Ray Mankoski, MD, PhD

Advisor to the African Healthcare Association

Ray Mankoski is a strategic healthcare leader with more than 15 years of global biopharma experience across oncology, rare diseases, pediatrics, and neuropsychiatry. Known for his optimistic, solutions-driven approach, Ray blends scientific depth with practical leadership to help organizations navigate complex healthcare challenges. As an advisor to the African Healthcare Association, Ray brings expertise in Medical Affairs, evidence generation, regulatory strategy, and long-range planning. His ability to translate science into scalable, patient-centered solutions makes him a trusted guide for partners working to strengthen healthcare systems and expand access across the continent.

WHAT WE WILL DISCUSS

Four focused threads.

Connecting the year’s most consequential oncology evidence to clinical decisions on the ground in Africa.

The most important practice-changing studies in 2026

Clear, accessible explanations of the clinical studies shaping care for patients in the U.S. and globally, and why they matter. Expect a curated walk-through of the year’s most consequential phase III trials and regulatory milestones, with plain-language commentary on what the data actually says, what it does not, and where the field is heading next.

When and how these breakthroughs can be implemented in African settings

A practical look at timelines, feasibility, and what health systems need to adopt new standards of care. The conversation will cover regulatory pathways, supply chain and access considerations, diagnostic infrastructure, workforce readiness, and the partnerships that turn approval into availability for African patients.

Evidence that can be applied now for African patients

Realistic, high-impact clinical insights that clinicians, researchers, and health leaders can use immediately. Where new evidence intersects with existing tools, protocols, and resources already available across African oncology practice, our speakers will identify the highest-yield changes you can make today.

How innovation and evidence translate into better outcomes

A cross-sector conversation on strengthening care delivery, improving access, and building research capacity across the continent. We will examine how clinical practice, industry strategy, advocacy, and policy can work together to close the gap between global innovation and African patient outcomes.